West Pharmaceutical Services | WST - Gross Profit On Sales

Stock Price
292.13
Daily Change
-10.07 -3.33%
Monthly
19.17%
Yearly
36.85%
Q2 Forecast
299.61

West Pharmaceutical Services reported $296.4M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Align Technology USD 683.59M 44.39M Dec/2025
Avanos Medical USD 86M 0 Dec/2025
Baxter International USD 577M 373M Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Cerus USD 33.33M 8.66M Dec/2024
Charles River Laboratories USD 271.96M 39.43M Dec/2025
Cooper Companies USD 695.2M 44.4M Dec/2025
Dentsply International USD 443M 2M Dec/2025
Haemonetics USD 202.39M 7.64M Dec/2025
ICU Medical USD 202.98M 2.1M Dec/2025
Insulet USD 568.6M 58.5M Dec/2025
Integra LifeSciences USD 217.1M 10.11M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
J&J USD 17.24B 642M Mar/2026
Medtronic USD 5.41B 27M Dec/2025
Merit Medical Systems USD 195.35M 8.94M Dec/2025
Neogen USD 99M 7.7M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Quidel USD 274.8M 1.01B Dec/2025
Repligen USD 103.83M 3.32M Dec/2025
Rockwell Medical USD 4.55M 1.49M Jun/2024
Solventum Corp USD 1.03B 108M Dec/2025
STAAR Surgical USD 43.74M 34.13M Dec/2025
Terumo JPY 153.19B 6.2B Dec/2025
Utah Medical Products USD 5.8M 450K Sep/2024
West Pharmaceutical Services USD 296.4M 7.5M Mar/2026